Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Return on Assets [ROA] (2011 - 2026)

Updated

Ligand Pharmaceuticals (LGND) reported Return on Assets [ROA] of 10.61% for Q2 2026, up 18.79 percentage points from -8.18% a year earlier and up 0.68 percentage points from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Ligand Pharmaceuticals posted Return on Assets [ROA] of 9.95%, up 10.41 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of +10.16 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -0.47% in FY2024 (-7.20 pp), 6.73% in FY2023 (+9.97 pp), -3.24% in FY2022 (-7.53 pp) and 4.30% in FY2021 (+4.51 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q1 2024.
  • Year over year, Return on Assets [ROA] has now increased in each of the last three quarters, with an average year-over-year change of +0.98 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q1 2026 (a gain of 24.29 percentage points); the low point was Q1 2025 (a drop of 25.69 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 9.93% (Q1 2026), 8.19% (Q4 2025) and 4.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - 10.61%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.61%
Mar 31, 2026 9.93%
Dec 31, 2025 8.19%
Sep 30, 2025 4.01%
Jun 30, 2025 -8.18%
Mar 31, 2025 -14.36%
Dec 31, 2024 -0.43%
Sep 30, 2024 4.97%
Jun 30, 2024 4.73%
Mar 31, 2024 11.33%
Dec 31, 2023 6.70%
Sep 30, 2023 2.16%
Jun 30, 2023 3.46%
Mar 31, 2023 3.05%
Dec 31, 2022 -3.68%
Sep 30, 2022 -2.00%
Jun 30, 2022 -0.73%
Mar 31, 2022 1.97%
Dec 31, 2021 4.44%
Sep 30, 2021 6.34%
API Access

Ligand Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LGND&period=max&api_key=YOUR_API_KEY